1.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 55
Sponsor: Other
Protocol IDs: GMALL02, NCT00198978
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL01, NCT00198991
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
|
|
4.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 15
Sponsor: Other
Protocol IDs: GMALL05, NCT00199082
|
|
5.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: G-PCNSL-SG1, NCT00153530
|
|
6.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 0 to 75
Sponsor: Other
Protocol IDs: LPA 2005, NCT00408278
|
|
7.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2006-003750-23, LINFOTARGAM, NCT00466258
|
|
8.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 and under
Sponsor: Other
Protocol IDs: LAL-BR/2001, NCT00526175
|
|
9.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 and under
Sponsor: Other
Protocol IDs: LAL-AR-N-2005, NCT00526409
|
|
10.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
|
|
11.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 and under
Sponsor: Other
Protocol IDs: 2007016, NCT00846703
|
|
12.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: LAL-AR/2003, NCT00853008
|
|
13.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: NILG-ALL 10/07, NCT00795756
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 18
Sponsor: Other
Protocol IDs: EORTC-58951, NCT00003728
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 22
Sponsor: Other
Protocol IDs: FRE-IGR-ALCL99, EU-20031, NHL2000/06, NCT00006455
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: CKTO-2000-06, HOVON-44, HOVON-44/CKVO-2000-06, EU-20042, ISRCTN95614846, NCT00012051
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: IBCSG-22-00, EU-20119, NCT00022516, EUDRACT-2005-005666-36
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: EORTC-30994, ACOSOG-EORTC-30994, CAN-NCIC-EORTC-30994, FNCLCC-GETUG-EORTC-30994, NORDIC-EORTC-30994, UKCCCR-EORTC-30994, NCRI-BLADDER-EORTC-30994, NCT00028756
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: COG-AALL0232, NCT00075725, AALL0232
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 10
Sponsor: NCI
Protocol IDs: COG-AALL0331, AALL0331, NCT00103285
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 5 to 40 at diagnostic biopsy
Sponsor: NCI
Protocol IDs: COG-AOST0331, AOST0331, NCT00134030, ISRCTN67613327, EU-20530, MRC-EURAMOS1, MRC-BO08, EUDRACT-2004-000242-20
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 25 to 65
Sponsor: Other
Protocol IDs: JALSG ALL202-O, NCT00131027
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 230704-HMO-CTIL, NCT00226512
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 3 to 18
Sponsor: Other
Protocol IDs: GPOH-HIT-GBM-D, EU-205100, NCT00278278
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: ICR-TACT2, EU-205114, EUDRACT-2004-000066-13, MREC-04/MRE00/88, ISRCTN68068041, NCT00301925
|
